Nanomedicine News

RSS

Comprehensive Report on Global Nanomedicine Market

Reportbuyer.com has added a new market research report: Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019

22 May 2014

Recent Advances in Tekmira’s Clinical Programs Presented at American Society of Gene and Cell Therapy Annual Meeting

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, announced that recent advances in its clinical programs were presented at the 17th Annual Meeting of the American Society of Gene and Cell Therapy, which is taking place in in Washington, DC, May 21 to 24.

22 May 2014

Nanoparticle Based Vaccine to be Presented at AAPS National Biotechnology Conference

Innovative vaccine research will be unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference (NBC). The meeting takes place Monday, May 19- Wednesday, May 21 at the Sheraton San Diego Hotel and Marina.

22 May 2014

Phase II Clinical Trial Begins to Evaluate Genprex’ Oncoprex Nanoparticles for Lung Cancer

Genprex, Inc. announced today that it has enrolled the first patient in a clinical trial evaluating its lead product candidate Oncoprex® in combination with erlotinib (Tarceva®) for late-stage lung cancer patients.

21 May 2014

Innovative Nanoparticle-based Vaccine Research to be Presented at AAPS National Biotechnology Conference

21 May 2014

AADi, Celgene Enter Licensing Agreement for Nanoparticle-based Drug Candidate

AADi, LLC, a clinical stage biopharmaceutical company focused on treating diseases uniquely suited for nanotechnology approaches, today announced the inlicensing of ABI-009 from Celgene Corporation. ABI-009 is the nan...

21 May 2014

Ultra-Sensitive Nano-Chip can Detect Cancer at Early Stages

Today, the majority of cancers are detected on the macroscopic level, when the tumor is already composed of millions of cancer cells and the disease is starting to advance into a more mature phase.

19 May 2014

ASM 2014: New Outcome Data from Studies Using Nanosphere's Verigene Infectious Disease Tests Presented

Nanosphere, Inc., a company enhancing medicine through targeted molecular diagnostics, today announced that new performance and clinical outcome data for three Verigene® multiplex infectious disease tests will be presented at the 114th General Meeting of the American Society for Microbiology (asm2014), to be held in Boston, Massachusetts on May 17 – 20, 2014.

19 May 2014

Novavax Reports One Year Follow-Up Data from RSV F-Protein Vaccine Candidate Phase 1 Elderly Trial

Novavax, Inc. today announced follow-up data from its dose-ranging Phase 1 clinical trial of its respiratory syncytial virus (RSV) F-protein vaccine in 220 elderly adults (60 years of age and older, with a mean age of 68) that was initiated in October 2012.

From Novavax Inc. 13 May 2014

NPL to Develop Methodologies to Measure Radio-Biological Impact of Gold Nanoparticles

A new project at the National Physical Laboratory (NPL) will develop methodologies to measure the radio-biological impact of gold nanoparticles, when used in combination with ionising radiation for enhancing radiotherapy treatments and medical imaging.

13 May 2014

Nanomedicine News

Comprehensive Report on Global Nanomedicine Market

Recent Advances in Tekmira’s Clinical Programs Presented at American Society of Gene and Cell Therapy Annual Meeting

Nanoparticle Based Vaccine to be Presented at AAPS National Biotechnology Conference

Phase II Clinical Trial Begins to Evaluate Genprex’ Oncoprex Nanoparticles for Lung Cancer

Innovative Nanoparticle-based Vaccine Research to be Presented at AAPS National Biotechnology Conference

AADi, Celgene Enter Licensing Agreement for Nanoparticle-based Drug Candidate

Ultra-Sensitive Nano-Chip can Detect Cancer at Early Stages

ASM 2014: New Outcome Data from Studies Using Nanosphere's Verigene Infectious Disease Tests Presented

Novavax Reports One Year Follow-Up Data from RSV F-Protein Vaccine Candidate Phase 1 Elderly Trial

NPL to Develop Methodologies to Measure Radio-Biological Impact of Gold Nanoparticles

Combining Nanofluids and Turbulators for Sustainable Energy

Enhancing Material Properties through Nanotube Encapsulation

Sustainable Carbon Nanomaterial Gii Set to Transform Energy Storage in Internet of Things Devices

Brain-Inspired Nano-Tech Promises New Era for Electronics

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials